AJPB® Translating Evidence-Based Research Into Value-Based Decisions®
AJPB® August 2022
Advertisement
Advertisement
Trending on Pharmacy Times
1
Updates in Treatment of Unresectable Hepatocellular Carcinoma
2
Soaring off the Patent Cliff: Preparing for the Next Wave of Oncology Biosimilars
3
Infliximab and Adalimumab Biosimilars Maintain Comparable Safety, Efficacy, Immunogenicity in IBD
4
Notable Updates in Medication Therapy Management in 2025
5